ReviewFrontiers in immunology2021

Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.

Xiaotian Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.